Marlo Whitehead

5.5k total citations · 2 hit papers
82 papers, 4.3k citations indexed

About

Marlo Whitehead is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Ophthalmology. According to data from OpenAlex, Marlo Whitehead has authored 82 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Oncology, 20 papers in Pulmonary and Respiratory Medicine and 13 papers in Ophthalmology. Recurrent topics in Marlo Whitehead's work include Lung Cancer Treatments and Mutations (16 papers), Global Cancer Incidence and Screening (11 papers) and Colorectal Cancer Screening and Detection (8 papers). Marlo Whitehead is often cited by papers focused on Lung Cancer Treatments and Mutations (16 papers), Global Cancer Incidence and Screening (11 papers) and Colorectal Cancer Screening and Detection (8 papers). Marlo Whitehead collaborates with scholars based in Canada, United States and United Kingdom. Marlo Whitehead's co-authors include Lesley Seymour, Frances A. Shepherd, Keyue Ding, Ming‐Sound Tsao, Chang‐Qi Zhu, Akira Sakurada, Ni Liu, Suzanne Kamel‐Reid, Tong Zhang and Gilda da Cunha Santos and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Gastroenterology.

In The Last Decade

Marlo Whitehead

81 papers receiving 4.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Erlotinib in Lung Cancer — Molecular and Clinical Predictors of Outcome

2005 1.5k citations Ming‐Sound Tsao, Akira Sakurada et al. profile →
Role of KRAS and EGFR As Biomarkers of Response to Erlotinib in National Cancer Institute of Canada Clinical Trials Group Study BR.21

2008 561 citations Chang‐Qi Zhu, Gilda da Cunha Santos et al. Journal of Clinical Oncology profile →

Peers

Countries citing papers authored by Marlo Whitehead

Since Specialization

Citations

This map shows the geographic impact of Marlo Whitehead's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marlo Whitehead with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marlo Whitehead more than expected).

Fields of papers citing papers by Marlo Whitehead

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marlo Whitehead. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marlo Whitehead. The network helps show where Marlo Whitehead may publish in the future.

Co-authorship network of co-authors of Marlo Whitehead

This figure shows the co-authorship network connecting the top 25 collaborators of Marlo Whitehead. A scholar is included among the top collaborators of Marlo Whitehead based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marlo Whitehead. Marlo Whitehead is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Real‐world colorectal cancer diagnostic pathways in Ontario, Canada: A population‐based study 2022 ·European Journal of Cancer Care ·(unknown), Colleen Webber, Jennifer A. Flemming, (unknown), Marlo Whitehead, Bingshu E. Chen, Patti A. Groome	3
2	Canadian Veteran chronic disease prevalence and health services use in the five years following release: a matched retrospective cohort study using routinely collected data 2022 ·BMC Public Health ·Alyson Mahar, Kate St. Cyr, Jennifer Enns, Alice Aiken, Marlo Whitehead, Heidi Cramm, Paul Kurdyak	2
3	Factors associated with waiting time to breast cancer diagnosis among symptomatic breast cancer patients: a population-based study from Ontario, Canada 2021 ·Breast Cancer Research and Treatment ·Colleen Webber, Marlo Whitehead, Andrea Eisen, (unknown), Patti A. Groome	6
4	Sex-specific differences in physical health and health services use among Canadian Veterans: a retrospective cohort study using healthcare administrative data 2021 ·BMJ Military Health ·Kate St. Cyr, Alice Aiken, Heidi Cramm, Marlo Whitehead, Paul Kurdyak, Alyson Mahar	4
5	The association of gender and persistent opioid use following an acute pain event: A retrospective population based study of renal colic 2021 ·PLoS ONE ·Melanie Jaeger, (unknown), Thomas McGregor, Darren Beiko, (unknown), Christopher M. Booth, Marlo Whitehead, D. Robert Siemens	3
6	Predictors of Initial Glaucoma Therapy with Laser Trabeculoplasty versus Medication 2020 ·Ophthalmology Glaucoma ·(unknown), Davin Johnson, Marlo Whitehead, Sudeep S. Gill, Chaim M. Bell	4
7	Association Between Exposure to General Versus Regional Anesthesia and Risk of Dementia in Older Adults 2020 ·Journal of the American Geriatrics Society ·(unknown), Miles Berger, Sudeep S. Gill, Roderic G. Eckenhoff, Heather Stuart, Marlo Whitehead, Peter C. Austin, Paula A. Rochon, Dallas Seitz	16
8	A retrospective cohort study comparing non-fatal self-harm emergency department visits between Canadian veterans living in Ontario and matched civilians 2019 ·International Review of Psychiatry ·Alyson Mahar, Heidi Cramm, Alice Aiken, Marlo Whitehead, Homer Tien, Nicola T. Fear, Paul Kurdyak	5
9	Persistent Opioid Use Among Patients with Urolithiasis: A Population based Study 2019 ·European Urology Focus ·(unknown), Thomas McGregor, Darren Beiko, Melanie Jaeger, Christopher M. Booth, Marlo Whitehead, D. Robert Siemens	14
10	Suicide in Canadian veterans living in Ontario: a retrospective cohort study linking routinely collected data 2019 ·BMJ Open ·Alyson Mahar, Alice Aiken, Marlo Whitehead, Homer Tien, Heidi Cramm, Nicola T. Fear, Paul Kurdyak	5
11	Changes in primary care provider utilization by phase of care for women diagnosed with breast cancer: a CanIMPACT longitudinal cohort study 2019 ·BMC Family Practice ·(unknown), Kathleen Decker, Rahim Moineddin, Cynthia Kendell, Robin Urquhart, (unknown), Patti A. Groome, Mary L. McBride, Marcy Winget, Marlo Whitehead, Eva Grunfeld	6
12	Adherence to quality breast cancer survivorship care in four Canadian provinces: a CanIMPACT retrospective cohort study 2019 ·BMC Cancer ·(unknown), Mary L. McBride, Patti A. Groome, Kathleen Decker, Cynthia Kendell, (unknown), Marlo Whitehead, Dongdong Li, Eva Grunfeld	15
13	Organized screening detects breast cancer at earlier stage regardless of molecular phenotype 2018 ·Journal of Cancer Research and Clinical Oncology ·Claire Holloway, (unknown), Marlo Whitehead, Jennifer M. Racz, Patti A. Groome	4
14	Anesthesia Assistance in Outpatient Colonoscopy and Risk of Aspiration Pneumonia, Bowel Perforation, and Splenic Injury 2017 ·Gastroenterology ·Barbara Bielawska, Lawrence Hookey, Rinku Sutradhar, Marlo Whitehead, Jianfeng Xu, Lawrence Paszat, Linda Rabeneck, Jill Tinmouth	59
15	New Surgeon Outcomes and the Effectiveness of Surgical Training 2017 ·Ophthalmology ·Chaim M. Bell, Sherif El-Defrawy, Sudeep S. Gill, Marlo Whitehead, (unknown), Philip L. Hooper, Martin ten Hove	26
16	Economies of scale: body mass index and costs of cardiac surgery in Ontario, Canada 2016 ·The European Journal of Health Economics ·Ana Johnson, Joel L. Parlow, Brian Milne, Marlo Whitehead, Jianfeng Xu, Susan L. Rohland, (unknown)	9
17	Adverse Gastrointestinal Events with Intravitreal Injection of Vascular Endothelial Growth Factor Inhibitors: Nested Case–Control Study 2014 ·Drug Safety ·Chaim M. Bell, Susan E. Bronskill, J. Michael Paterson, Marlo Whitehead, (unknown), Sudeep S. Gill	3
18	Role of KRAS and EGFR As Biomarkers of Response to Erlotinib in National Cancer Institute of Canada Clinical Trials Group Study BR.21 breakdown → 2008 ·Journal of Clinical Oncology ·Chang‐Qi Zhu, Gilda da Cunha Santos, Keyue Ding, Akira Sakurada, Jean-Claude Cutz, Ni Liu, Tong Zhang, Paula Marrano, Marlo Whitehead, Jeremy A. Squire, Suzanne Kamel‐Reid, Lesley Seymour, Frances A. Shepherd, Ming‐Sound Tsao	561
19	Validation of treatment induced specific adverse effect as a predictor of treatment benefit: A case study of NCIC CTG BR21 2008 ·Contemporary Clinical Trials ·Keyue Ding, Joseph L. Pater, Marlo Whitehead, Lesley Seymour, Frances A. Shepherd	14
20	Smoking History and Epidermal Growth Factor Receptor Expression as Predictors of Survival Benefit from Erlotinib for Patients with Non–Small-Cell Lung Cancer in the National Cancer Institute of Canada Clinical Trials Group Study BR.21 2006 ·Clinical Lung Cancer ·Gary M. Clark, (unknown), P. Santabárbara, Keyue Ding, Marlo Whitehead, Lesley Seymour, Frances A. Shepherd	140

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact